Amyris scales production of its first yeast-created cannabinoid

Mugglehead
By Nick LabaSep 1, 2020, 7:25 pm209 pts
‘Move over CBD,’ is the attitude of Amyris, Inc. (Nasdaq: AMRS) which says it’s successfully scaled the commercial production of it’s first cannabinoid, cannabigerol. In a statement Tuesday, the U.S. synthetic biotech company said it expects to deliver around 1,000 kilograms of high-purity CBG via its…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas gov. makes final hour decision on hemp ban 69

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 62

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.